BPO 0.00% 0.3¢ bioprospect limited

chalk'n this down as a buy, page-37

  1. 6,187 Posts.
    lightbulb Created with Sketch. 497
    Nothing in anns due unless Re-Gen product progress closer than expected, APVEMA approval not due to late Q409. Hey if someone had a large holding to leverage, the SP can rises on little vol [all to not a great deal of sellers and few traders around now].
 
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.